F2R and neoplasm: Previously, we showed that PAR1 expression in PDAC stroma drives tumor progression [25] and the lack of association between PAR1 and overall survival in PDAC patients lead us to reason that tumor cell-specific PAR1 might counteract the tumorigenic stromal PAR1 activity and reduces the detrimental effect on overall survival.